Advancing Cancer Diagnostics with Molecular Precision
BioGenex delivers cutting-edge molecular pathology technologies designed to improve cancer diagnosis, prognosis, and precision medicine. With fully automated systems, advanced reagents, and intelligent workflows, we empower laboratories to achieve faster, more accurate, and reproducible diagnostic outcomes. More than 43 years ahead of the competition, systems and product performance are guaranteed: antibodies, probes, antigen retrieval, detection systems, and histology stains with more than 600+ AB .
Key Product Categories
Immunohistochemistry (IHC)
Advanced IHC solutions deliver sensitivity and specificity for precise antigen detection, enabling accurate tumor classification and therapy selection with excellent reproducibility.
In Situ Hybridization (ISH)
Detect and localize nucleic acid sequences with high precision using automated ISH systems, probes, and detection technologies for reliable diagnostics.
Fluorescence In Situ Hybridization
Industry-leading FISH workflows provide detailed genetic insights for cancer diagnosis, including detection of chromosomal abnormalities and complex mutations.
Multiplexing Technologies
Simultaneously analyze multiple biomarkers within a single tissue sample, enabling deeper insights into disease mechanisms and improving diagnostic efficiency.
microRNA (miRNA) Analysis
Advanced miRNA probe systems support the characterization of complex cancers, including cancers of unknown primary origin, enhancing diagnostic accuracy.
Automated Workstations
Fully automated systems streamline slide-based assays, reducing manual intervention and increasing throughput across pathology workflows.
Why Choose BioGenex?
Complete End-to-End Solutions
High Throughput & Automation
Precision & Reproducibility
Innovation-Driven Technology
